Page last updated: 2024-08-25

rosiglitazone and Hypertriglyceridemia

rosiglitazone has been researched along with Hypertriglyceridemia in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, JP; Bergman, JP; Desai, RC; Doebber, TW; Gratale, DF; Han, W; Heck, JV; Leung, K; MacNaul, KL; Metzger, EJ; Moller, DE; Sahoo, SP	1
Kazdova, L; Kren, V; Krenova, D; Seda, O	1
Ehrenborg, E; Eriksson, P; Fisher, RM; Hamsten, A; Kannisto, K; Korsheninnikova, E; Silveira, A; Sutinen, J; Yki-Järvinen, H	1
Abchee, AB; Alam, S; Ayach, K; Dakik, HA; Mehio-Sibai, A; Nasrallah, A; Sawaya, J; Sibai, T; Skouri, HN; Wehbeh, C	1
Chen, X; Cryan, E; Demarest, KT; Osborne, MC; Rybczynski, PJ; Tang, Y; Xu, J; Yang, M; Zeck, R; Zhou, L	1
Bujko, J; Dzieniszewski, J; Nowicka, G; Tacikowski, T; Walewska-Zielecka, B	1
Brandlhofer, S; Dorfmeister, B; Fürnsinn, C; Hagerty, BP; Hermann, M; Patsch, W; Schaap, FG; Stangl, H; Strobl, W	1
Daubresse, JC	1
Jacinto, SM; Ljung, B; Oakes, ND; Thalén, PG	1

Reviews

1 review(s) available for rosiglitazone and Hypertriglyceridemia

Article	Year
[The importance of syndrome X in daily practice]. Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6 Topics: Anthropometry; Cardiovascular Diseases; Diet, Reducing; Exercise; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Lipoproteins, HDL; Lipoproteins, LDL; Obesity; Rosiglitazone; Thiazoles; Thiazolidinediones	2000

Trials

1 trial(s) available for rosiglitazone and Hypertriglyceridemia

Article	Year
Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arteriosclerosis, thrombosis, and vascular biology, 2003, Apr-01, Volume: 23, Issue:4 Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Female; HIV Infections; Humans; Hyperinsulinism; Hypertriglyceridemia; Interleukin-6; Leptin; Lipodystrophy; Liver; Male; Middle Aged; Organ Specificity; Plasminogen Activator Inhibitor 1; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Subcutaneous Tissue; Thiazolidinediones; Transcription Factors	2003

Article

Year

Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.

Arteriosclerosis, thrombosis, and vascular biology, 2003, Apr-01, Volume: 23, Issue:4

Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Female; HIV Infections; Humans; Hyperinsulinism; Hypertriglyceridemia; Interleukin-6; Leptin; Lipodystrophy; Liver; Male; Middle Aged; Organ Specificity; Plasminogen Activator Inhibitor 1; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Subcutaneous Tissue; Thiazolidinediones; Transcription Factors

2003

Other Studies

7 other study(ies) available for rosiglitazone and Hypertriglyceridemia

Article	Year
5-aryl thiazolidine-2,4-diones: discovery of PPAR dual alpha/gamma agonists as antidiabetic agents. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Administration, Oral; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones; Transcription Factors	2003
Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain. Physiological genomics, 2003, Jan-15, Volume: 12, Issue:2 Topics: Adipocytes; Adipose Tissue; Administration, Oral; Animals; Body Composition; CD36 Antigens; Diet; Dietary Sucrose; Glucose Intolerance; Glucose Tolerance Test; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Male; Rats; Rats, Inbred BN; Rats, Inbred SHR; Rosiglitazone; Thiazoles; Thiazolidinediones	2003
Prevalence of coronary artery calcium among asymptomatic men and women in a developing country: comparison with the USA data. Atherosclerosis, 2005, Volume: 183, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Calcinosis; Calcium; Comorbidity; Coronary Artery Disease; Coronary Vessels; Developing Countries; Diabetes Mellitus, Type 2; Female; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Lebanon; Male; Middle Aged; Prevalence; Risk Factors; Rosiglitazone; Smoking; Thiazolidinediones; Tomography, X-Ray Computed; United States	2005
Pharmacological profile of a novel, non-TZD PPARgamma agonist. Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:5 Topics: Adipocytes; Animals; Benzoxazines; Blood Glucose; Diabetes Mellitus, Experimental; Female; Gene Expression Regulation; Glycated Hemoglobin; Hepatocytes; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Lipid Metabolism; Male; Mice; Mice, Obese; PPAR gamma; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Triglycerides	2005
[Effect of high-fat diet, rosiglitazone on lipid profile, insulin resistance and liver steatosis development]. Polskie Archiwum Medycyny Wewnetrznej, 2005, Volume: 113, Issue:3 Topics: Animals; Blood Glucose; Cholesterol; Dietary Fats; Fatty Liver; Hypercholesterolemia; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Peptides; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Triglycerides	2005
Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats. Diabetologia, 2006, Volume: 49, Issue:6 Topics: Animals; Apolipoprotein A-V; Apolipoproteins; Base Sequence; Cholesterol; Dietary Fats; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Fish Oils; Hypertriglyceridemia; Insulin; Molecular Sequence Data; Obesity; PPAR gamma; Rats; Rats, Zucker; RNA, Messenger; Rosiglitazone; Sequence Alignment; Sequence Homology, Nucleic Acid; Thiazolidinediones; Triglycerides	2006
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes, 2001, Volume: 50, Issue:5 Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Fasting; Fatty Acids, Nonesterified; Glucose Clamp Technique; Humans; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Kinetics; Lipid Mobilization; Lipoproteins, VLDL; Liver; Male; Metabolic Clearance Rate; Muscle, Skeletal; Obesity; Oxidation-Reduction; Polyethylene Glycols; Postprandial Period; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Triglycerides	2001